• Je něco špatně v tomto záznamu ?

Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial Fibrillation

MK. Turagam, P. Neuzil, B. Schmidt, T. Reichlin, K. Neven, A. Metzner, J. Hansen, Y. Blaauw, P. Maury, T. Arentz, P. Sommer, A. Anic, F. Anselme, S. Boveda, T. Deneke, S. Willems, P. van der Voort, R. Tilz, M. Funasako, D. Scherr, R. Wakili, D....

. 2024 ; 10 (5) : 900-912. [pub] 20240131

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014143

BACKGROUND: Pulmonary vein isolation (PVI) alone is insufficient to treat many patients with persistent atrial fibrillation (PersAF). Adjunctive left atrial posterior wall (LAPW) ablation with thermal technologies has revealed lack of efficacy, perhaps limited by the difficulty in achieving lesion durability amid concerns of esophageal injury. OBJECTIVES: This study aims to compare the safety and effectiveness of PVI + LAPW ablation vs PVI in patients with PersAF using pulsed-field ablation (PFA). METHODS: In a retrospective analysis of the MANIFEST-PF (Multi-National Survey on the Methods, Efficacy, and Safety on the Post-approval Clinical Use of Pulsed Field Ablation) registry, we studied consecutive PersAF patients undergoing post-approval treatment with a pentaspline PFA catheter. The primary effectiveness outcome was freedom from any atrial arrhythmia of ≥30 seconds. Safety outcomes included the composite of acute and chronic major adverse events. RESULTS: Of the 547 patients with PersAF who underwent PFA, 131 (24%) received adjunctive LAPW ablation. Compared to PVI-alone, patients receiving adjunctive LAPW ablation were younger (65 vs 67 years of age, P = 0.08), had a lower CHA2DS2-VASc score (2.3 ± 1.6 vs 2.6 ± 1.6, P = 0.08), and were more likely to receive electroanatomical mapping (48.1% vs 39.0%, P = 0.07) and intracardiac echocardiography imaging (46.1% vs 17.1%, P < 0.001). The 1-year Kaplan-Meier estimate for freedom from atrial arrhythmias was not statistically different between groups in the full (PVI + LAPW: 66.4%; 95% CI: 57.6%-74.4% vs PVI: 73.1%; 95% CI: 68.5%-77.2%; P = 0.68) and propensity-matched cohorts (PVI + LAPW: 71.7% vs PVI: 68.5%; P = 0.34). There was also no significant difference in major adverse events between the groups (2.2% vs 1.4%, respectively, P = 0.51). CONCLUSIONS: In patients with PersAF undergoing PFA, as compared to PVI-alone, adjunctive LAPW ablation did not improve freedom from atrial arrhythmia at 12 months.

Asklepios Hospital St Georg Hamburg Germany

Cardiology Department Na Homolce Hospital Homolka Hospital Prague Czech Republic

Catharina Hospital Eindhoven the Netherlands

Clinic for Electrophysiology Herz und Diabeteszentrum NRW Ruhr University Bochum Bad Oeynhausen Germany

Department for Cardiovascular Diseases University Hospital Center Split Split Croatia

Department of Cardiology and Angiology Medical Center and Faculty of Medicine University of Freiburg Freiburg Germany

Department of Cardiology and Vascular Medicine West German Heart and Vascular Center Essen University Duisburg Essen Duisburg Germany

Department of Cardiology Herlev Gentofte University Hospital Hellerup Denmark

Department of Cardiology Jessa Hospitals Hasselt Belgium

Department of Cardiology Rouen Hospital Rouen France

Department of Cardiology University Hospital Rangueil Toulouse France

Department of Cardiology University of Groningen University Medical Center Groningen Groningen the Netherlands

Department of Electrophysiology Alfried Krupp Hospital Essen Germany

Department of Medicine Witten Herdecke University Witten Germany

Division of Cardiology Department of Internal Medicine Medical University of Graz Graz Austria

German Center for Cardiovascular Research Partner Site Hamburg Kiel Lübeck Lübeck Germany

Heart Center Bad Neustadt Rhoen Clinic Campus Bad Neustadt Bad Neustadt an der Saale Germany

Heart Center University Hospital of Cologne Department for Electrophysiology Cologne Germany

Heart Rhythm Department Clinique Pasteur Toulouse France

I2MC INSERM UMR 1297 Toulouse France

Icahn School of Medicine at Mount Sinai New York New York USA

IHU LIRYC CHU Bordeaux University of Bordeaux Pessac France

IKEM Institute for Clinical and Experimental Medicine Prague Czech Republic

Inselspital Bern University Hospital University of Bern Bern Switzerland

MVZ CCB Frankfurt und Main Taunus GbR Frankfurt Germany

Neuron Medical Brno Czech Republic

Universitair Ziekenhuis VUB Brussels Belgium

University Heart and Vascular Center University Medical Center Hamburg Eppendorf Hamburg Germany

University Heart Center Lübeck Department of Rhythmology University Hospital Schleswig Holstein Lübeck Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014143
003      
CZ-PrNML
005      
20240905134325.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacep.2024.01.017 $2 doi
035    __
$a (PubMed)38430087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Turagam, Mohit K $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
245    10
$a Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial Fibrillation / $c MK. Turagam, P. Neuzil, B. Schmidt, T. Reichlin, K. Neven, A. Metzner, J. Hansen, Y. Blaauw, P. Maury, T. Arentz, P. Sommer, A. Anic, F. Anselme, S. Boveda, T. Deneke, S. Willems, P. van der Voort, R. Tilz, M. Funasako, D. Scherr, R. Wakili, D. Steven, J. Kautzner, J. Vijgen, P. Jais, J. Petru, J. Chun, L. Roten, A. Füting, MD. Lemoine, M. Ruwald, BA. Mulder, A. Rollin, H. Lehrmann, T. Fink, Z. Jurisic, C. Chaumont, R. Adelino, K. Nentwich, M. Gunawardene, A. Ouss, CH. Heeger, M. Manninger, JE. Bohnen, A. Sultan, P. Peichl, P. Koopman, N. Derval, T. Kueffer, N. Reinsch, VY. Reddy
520    9_
$a BACKGROUND: Pulmonary vein isolation (PVI) alone is insufficient to treat many patients with persistent atrial fibrillation (PersAF). Adjunctive left atrial posterior wall (LAPW) ablation with thermal technologies has revealed lack of efficacy, perhaps limited by the difficulty in achieving lesion durability amid concerns of esophageal injury. OBJECTIVES: This study aims to compare the safety and effectiveness of PVI + LAPW ablation vs PVI in patients with PersAF using pulsed-field ablation (PFA). METHODS: In a retrospective analysis of the MANIFEST-PF (Multi-National Survey on the Methods, Efficacy, and Safety on the Post-approval Clinical Use of Pulsed Field Ablation) registry, we studied consecutive PersAF patients undergoing post-approval treatment with a pentaspline PFA catheter. The primary effectiveness outcome was freedom from any atrial arrhythmia of ≥30 seconds. Safety outcomes included the composite of acute and chronic major adverse events. RESULTS: Of the 547 patients with PersAF who underwent PFA, 131 (24%) received adjunctive LAPW ablation. Compared to PVI-alone, patients receiving adjunctive LAPW ablation were younger (65 vs 67 years of age, P = 0.08), had a lower CHA2DS2-VASc score (2.3 ± 1.6 vs 2.6 ± 1.6, P = 0.08), and were more likely to receive electroanatomical mapping (48.1% vs 39.0%, P = 0.07) and intracardiac echocardiography imaging (46.1% vs 17.1%, P < 0.001). The 1-year Kaplan-Meier estimate for freedom from atrial arrhythmias was not statistically different between groups in the full (PVI + LAPW: 66.4%; 95% CI: 57.6%-74.4% vs PVI: 73.1%; 95% CI: 68.5%-77.2%; P = 0.68) and propensity-matched cohorts (PVI + LAPW: 71.7% vs PVI: 68.5%; P = 0.34). There was also no significant difference in major adverse events between the groups (2.2% vs 1.4%, respectively, P = 0.51). CONCLUSIONS: In patients with PersAF undergoing PFA, as compared to PVI-alone, adjunctive LAPW ablation did not improve freedom from atrial arrhythmia at 12 months.
650    _2
$a lidé $7 D006801
650    12
$a fibrilace síní $x chirurgie $7 D001281
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a katetrizační ablace $x metody $x škodlivé účinky $7 D017115
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    12
$a srdeční síně $x chirurgie $7 D006325
650    12
$a venae pulmonales $x chirurgie $7 D011667
650    _2
$a výsledek terapie $7 D016896
650    _2
$a registrace $7 D012042
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuzil, Petr $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic
700    1_
$a Schmidt, Boris $u MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt, Germany
700    1_
$a Reichlin, Tobias $u Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Neven, Kars $u Department of Medicine, Witten/Herdecke University, Witten, Germany; Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany
700    1_
$a Metzner, Andreas $u University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Hansen, Jim $u Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark
700    1_
$a Blaauw, Yuri $u Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
700    1_
$a Maury, Philippe $u Department of Cardiology, University Hospital Rangueil, Toulouse, France; I2MC, INSERM UMR 1297, Toulouse, France
700    1_
$a Arentz, Thomas $u Department of Cardiology and Angiology, Medical Center and Faculty of Medicine-University of Freiburg, Freiburg, Germany
700    1_
$a Sommer, Philipp $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany
700    1_
$a Anic, Ante $u Department for Cardiovascular Diseases, University Hospital Center Split, Split, Croatia
700    1_
$a Anselme, Frederic $u Department of Cardiology, Rouen Hospital, Rouen, France
700    1_
$a Boveda, Serge $u Heart Rhythm Department, Clinique Pasteur, Toulouse, France; Universitair Ziekenhuis VUB, Brussels, Belgium
700    1_
$a Deneke, Tom $u Heart Center Bad Neustadt, Rhoen-Clinic Campus Bad Neustadt, Bad Neustadt an der Saale, Germany
700    1_
$a Willems, Stephan $u Asklepios Hospital St Georg, Hamburg, Germany
700    1_
$a van der Voort, Pepijn $u Catharina Hospital, Eindhoven, the Netherlands
700    1_
$a Tilz, Roland $u University Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany
700    1_
$a Funasako, Moritoshi $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic; Neuron Medical, Brno, Czech Republic
700    1_
$a Scherr, Daniel $u Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
700    1_
$a Wakili, Reza $u Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Duisburg, Germany
700    1_
$a Steven, Daniel $u Heart Center University Hospital of Cologne, Department for Electrophysiology, Cologne, Germany
700    1_
$a Kautzner, Josef $u IKEM-Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vijgen, Johan $u Department of Cardiology, Jessa Hospitals, Hasselt, Belgium
700    1_
$a Jais, Pierre $u IHU LIRYC, CHU Bordeaux, University of Bordeaux, Pessac, France
700    1_
$a Petru, Jan $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic
700    1_
$a Chun, Julian $u MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt, Germany
700    1_
$a Roten, Laurent $u Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Füting, Anna $u Department of Medicine, Witten/Herdecke University, Witten, Germany; Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany
700    1_
$a Lemoine, Marc D $u University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Ruwald, Martin $u Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark
700    1_
$a Mulder, Bart A $u Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
700    1_
$a Rollin, Anne $u Department of Cardiology, University Hospital Rangueil, Toulouse, France
700    1_
$a Lehrmann, Heiko $u Department of Cardiology and Angiology, Medical Center and Faculty of Medicine-University of Freiburg, Freiburg, Germany
700    1_
$a Fink, Thomas $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany
700    1_
$a Jurisic, Zrinka $u Department for Cardiovascular Diseases, University Hospital Center Split, Split, Croatia
700    1_
$a Chaumont, Corentin $u Department of Cardiology, Rouen Hospital, Rouen, France
700    1_
$a Adelino, Raquel $u Heart Rhythm Department, Clinique Pasteur, Toulouse, France; Universitair Ziekenhuis VUB, Brussels, Belgium
700    1_
$a Nentwich, Karin $u Heart Center Bad Neustadt, Rhoen-Clinic Campus Bad Neustadt, Bad Neustadt an der Saale, Germany
700    1_
$a Gunawardene, Melanie $u Asklepios Hospital St Georg, Hamburg, Germany
700    1_
$a Ouss, Alexandre $u Catharina Hospital, Eindhoven, the Netherlands
700    1_
$a Heeger, Christian-Hendrik $u University Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany
700    1_
$a Manninger, Martin $u Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
700    1_
$a Bohnen, Jan-Eric $u Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Duisburg, Germany
700    1_
$a Sultan, Arian $u Heart Center University Hospital of Cologne, Department for Electrophysiology, Cologne, Germany
700    1_
$a Peichl, Petr $u IKEM-Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Koopman, Pieter $u Department of Cardiology, Jessa Hospitals, Hasselt, Belgium
700    1_
$a Derval, Nicolas $u IHU LIRYC, CHU Bordeaux, University of Bordeaux, Pessac, France
700    1_
$a Kueffer, Thomas $u Inselspital-Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Reinsch, Nico $u Department of Medicine, Witten/Herdecke University, Witten, Germany; Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany
700    1_
$a Reddy, Vivek Y $u Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic. Electronic address: vivek.reddy@mountsinai.org
773    0_
$w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 10, č. 5 (2024), s. 900-912
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38430087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134319 $b ABA008
999    __
$a ok $b bmc $g 2143744 $s 1226009
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 10 $c 5 $d 900-912 $e 20240131 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...